Manufacturers/ViiV Healthcare Company

ViiV Healthcare Company

13 drugs in NADAC|0 Generic,13 Brand

ViiV Healthcare Company lists 13 NDCs in the CMS NADAC file (0 generic, 13 brand), at an average NADAC of $60.64 per unit, with a week-over-week move of +0.1% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.

Total Drugs

0G / 13B

Avg Price / Unit

$60.6405

$0.45 – $156.87

Avg 7d Change

+0.08%

Across 5 drugs with changes

7d Activity

3↑2↓8 flat

of 13 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Frequently Asked Questions

How many drugs does ViiV Healthcare Company make?

ViiV Healthcare Company lists 13 NDCs in the CMS NADAC file — 0 generic and 13 brand products.

What is the average price of ViiV Healthcare Company drugs?

The average NADAC across ViiV Healthcare Company's portfolio is $60.6405 per unit, ranging from $0.4452 to $156.8667.

What types of drugs does ViiV Healthcare Company make?

ViiV Healthcare Company makes drugs across 5 FDA pharmacologic classes. The most common by NDC count are Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor (10), Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor (7), Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor (5), CCR5 Co-receptor Antagonist (2), Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor (1).

Has ViiV Healthcare Company had any drug recalls?

1 FDA recall is matched to ViiV Healthcare Company in the openFDA feed, most recently on Feb 11, 2014.

How has ViiV Healthcare Company's pricing changed recently?

Over the past 7 days, 3 ViiV Healthcare Company products rose and 2 fell, with a portfolio-wide average change of +0.1%.

Drug Portfolio

13 drugs total, 13 shown

Drug ↕	NDC	Price	7d Change ↕	Class	Market Outlier	Therapeutic Class
RUKOBIA ER 600 MG TABLET fostemsavir tromethamine	49702025018	$156.8667 per EA	—	Brand	—	—
TRIUMEQ 600-50-300 MG TABLET abacavir sulfate, dolutegravir sodium, lamivudine	49702023113	$130.1047 per EA	-0.01%	Brand	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
JULUCA 50-25 MG TABLET dolutegravir sodium and rilpivirine hydrochloride	49702024213	$121.7683 per EA	+0.16%	Brand	—	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor
DOVATO 50-300 MG TABLET dolutegravir sodium and lamivudine	49702024613	$105.2551 per EA	+0.14%	Brand	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
DOVATO 50-300 MG TABLET dolutegravir sodium and lamivudine	49702024633	$105.2551 per EA	+0.14%	Brand	—	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
TIVICAY 50 MG TABLET dolutegravir sodium	49702022813	$77.5953 per EA	-0.03%	Brand	—	Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor
SELZENTRY 300 MG TABLET maraviroc	49702022418	$28.1311 per EA	—	Brand	High Outlier	CCR5 Co-receptor Antagonist
SELZENTRY 150 MG TABLET maraviroc	49702022318	$28.0158 per EA	—	Brand	High Outlier	CCR5 Co-receptor Antagonist
COMBIVIR TABLET lamivudine and zidovudine	49702020218	$14.3948 per EA	—	Brand	High Outlier	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EPIVIR 300 MG TABLET lamivudine	49702020413	$13.2940 per EA	—	Brand	High Outlier	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EPIVIR 150 MG TABLET lamivudine	49702020318	$6.6144 per EA	—	Brand	High Outlier	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
ZIAGEN 20 MG/ML SOLUTION abacavir sulfate	49702022248	$0.5865 per ML	—	Brand	—	Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
EPIVIR 10 MG/ML ORAL SOLN lamivudine	49702020548	$0.4452 per ML	—	Brand	High Outlier	Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor, Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

FDA Recalls (1)

Recalls matched by company name. Verify current status with FDA.

D-1185-2014 →

Terminated

Class III

Tivicay (dolutegravir) Tablets 50 mg, 30 Tablet Bottles, Rx Only. Manufactured for: ViiV Health, TRP, NC 27709; by: GlaxoSmithKline, Research Triangle Park, NC 27709. Made in Japan. NDC 49702-228-13

Cross Contamination with Other Products: Product contains Promacta (eltrombopag).

Initiated: 2/11/2014